|
KMID : 0387320130230030210
|
|
Korean Journal of Health Policy and Administration
2013 Volume.23 No. 3 p.210 ~ p.223
|
|
|
Lessons from Generic Promotion Policies in Other Countries
|
|
Kim Dong-Sook
Bae Seung-Jin
Jang Sun-Mee
|
|
|
Abstract
|
|
|
Background: Escalating pharmaceutical expenditure has threatened the sustainability of National Health Insurance system in Korea. Generic medicines allow patients to access safe, effective, high-quality medicines at low cost, thus insurers could achieve significant financial savings by promotion of generics, if they are priced much lower than the originator. The purpose of this study was to review generic pricing as well as promotion policies in other countries and assess the implication of those policies.
Methods: We reviewed the main measures adopted by the developed countries such as Austria, Belgium, Denmark, Finland, France, Germany, Italy, Japan, Netherlands, Norway, Sweden, United Kingdom, especially in countries where governments are the largest third-party payers or insurance finance resource is the national health insurance.
Results: The foreign countries’s experience with generic medicine policy shows that demand-side policies such as physician budgets, international nonproprietary name prescribing, generics substitution, patients co-payment as well as supply-side policies relating to pricing and reimbursement seems to play a critical role in developing the generic medicines market.
Conclusion: Various strategy should be implemented to promote generic drug use.
|
|
|
KEYWORD
|
|
|
Generic drugs, Drug policy, Costs and cost analysis, Generic use
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|